Primary Site >> Esophagus Cancer

Gene >> IL2

  • 1988
  • 1989
  • 1990
  • 1992
  • 1993
  • 1994
  • 1995
  • 1997
  • 1998
  • 1999
  • 2000
  • 2001
  • 2002
  • 2007
  • 2008
  • 2009
  • 2010
  • 2013
  • 2014
  • 2015
  • 2017
Ref: The regulation of natural killer cell activity by splenic nonspecific suppressor cells and its modification in cancer patients.
PMID: 2977625
 Ref: [Clinical efficacy of LAK cell adoptive immunotherapy in advanced cancer patients].
PMID: 2586438
Ref: [Experimental and clinical studies on intrapleural instillations of interleukin-2 (IL-2) in patients with malignant pleural effusion].
PMID: 2608022
 Ref: [Human LAK cell induction and its biological characteristics].
PMID: 2125554
 Ref: [Lymphokine-activated killer cell adoptive immunotherapy for cancer treatment and its significance].
PMID: 1334695
Ref: [Modulation effect of lithium on IL-2 and IFNr production by human peripheral blood mononuclear cells].
PMID: 1337888
Ref: Effect of anti-CD3 antibody on the generation of interleukin-2-activated lymphocytes from tumor tissues of gastrointestinal cancer.
PMID: 1386555
 Ref: The intrapleural administration of recombinant interleukin-2 (rIL-2) to patients with malignant pleural effusion: clinical trials.
PMID: 8118118
 Ref: [Immunocompetence of esophageal cancer patients with familial cancer history and their relatives].
PMID: 7956693
 Ref: Cytokine mRNA expression patterns in human esophageal cancer cell lines.
PMID: 8590302
 Ref: Neoadjuvant chemoimmunotherapy with cisplatin and low-dose interleukin-2 for locally advanced esophageal carcinoma
PMID: 10851490
 Ref: A breast and melanoma-shared tumor antigen: T cell responses to antigenic peptides translated from different open reading frames.
PMID: 9759882
Ref: Antitumor response of genetically engineered IL-2 expression to human esophageal carcinoma cells in mature T cell-defective condition.
PMID: 9824634
 Ref: Clinical application of adoptive immunotherapy and IL-2 for the treatment of advanced digestive tract cancer.
PMID: 10429974
 Ref: [The protocol of clinical trial and basic experiments for esophageal cancer using gene transduction].
PMID: 11004829
Ref: [Locoregional adoptive immunotherapy using LAK cells and IL-2 against liver metastases from digestive tract cancer].
PMID: 11086454
Ref: Cisplatin induces fas expression in esophageal cancer cell lines and enhanced cytotoxicity in combination with LAK cells.
PMID: 11096347
Ref: Locoregional cellular immunotherapy for patients with advanced esophageal cancer.
PMID: 11156218
 Ref: Electroporation-mediated transfer of cytokine genes into human esophageal tumors produces anti-tumor effects in mice.
PMID: 11724313
 Ref: Locoregional adoptive immunotherapy resulted in regression in distant metastases of a recurrent esophageal cancer.
PMID: 12494255
 Ref: [A dynamic observation on serum cytokine and immunoglobulin (IgG, IgA, IgM) in patients with esophageal cancer].
PMID: 17767855
 Ref: Genomic profiling of 766 cancer-related genes in archived esophageal normal and carcinoma tissues.
PMID: 18241037
Ref: Cytokine response following transthoracic and transhiatal esophagectomy in patients with esophageal cancer.
PMID: 18632423
 Ref: Interferon-gamma 874A>T genetic polymorphism is associated with infectious complications following surgery in patients with thoracic esophageal cancer.
PMID: 19733878
Ref: C-reactive protein 1059G>C genetic polymorphism influences serum C-reactive protein levels after esophagectomy in patients with thoracic esophageal cancer.
PMID: 19801321
 Ref: [Effects of different anesthetic and analgesic protocols on cellular immune function and stress hormone level in patients undergoing lobectomy for esophagus cancer].
PMID: 20159701
 Ref: Effect of early enteral nutrition on postoperative nutritional status and immune function in elderly patients with esophageal cancer or cardiac cancer.
PMID: 23825906
 Ref: The intensity of radiotherapy-elicited immune response is associated with esophageal cancer clearance.
PMID: 24967419
 Ref: Adoptive Transfer of MAGE-A4 T-cell Receptor Gene-Transduced Lymphocytes in Patients with Recurrent Esophageal Cancer.
PMID: 25855804
Ref: Effect of miR-503 Down-Regulation on Growth and Invasion of Esophagus Carcinoma and Related Immune Function.
PMID: 26580839
 Ref: A Dendritic Cell Vaccine Combined With Radiotherapy Activates the Specific Immune Response in Patients With Esophageal Cancer.
PMID: 28125513
Ref: Treatment of Patients With Metastatic Cancer Using a Major Histocompatibility Complex Class II-Restricted T-Cell Receptor Targeting the Cancer Germline Antigen MAGE-A3.
PMID: 28809608